Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update


29 juli, 14:05

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

PR Newswire

SOUTH SAN FRANCISCO, Calif., July 29, 2025

SOUTH SAN FRANCISCO, Calif. , July 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close on Tuesday, August 5 , 2025. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time ( 1:30 p.m. Pacific Time ) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com . The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California . For more information on Rigel, the Company's marketed products and pipeline of potential products, visit  www.rigel.com .

Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com

Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email:  david.rosen@argotpartners.com

Rigel Pharmaceuticals Logo (PRNewsfoto/Rigel Pharmaceuticals, Inc.)

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2025-financial-results-and-business-update-302515528.html

SOURCE Rigel Pharmaceuticals, Inc.

Läs mer på PR Newswire

Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.